key: cord-0808617-d16kczhs
authors: Dubourg, Grégory; Lagier, Jean-Christophe; Brouqui, Philippe; Casalta, Jean-Paul; Jacomo, Véronique; La Scola, Bernard; Rolain, Jean-Marc; Raoult, Didier
title: Low blood zinc concentrations in patients with poor clinical outcome during SARS-CoV-2 infection: is there a need to supplement with Zinc COVID-19 patients?
date: 2021-02-13
journal: J Microbiol Immunol Infect
DOI: 10.1016/j.jmii.2021.01.012
sha: 37dcb6098aaa59f60b0817af1992a80541c93f21
doc_id: 808617
cord_uid: d16kczhs

Among 275 patients with COVID-19, we found that median blood zinc level was significantly lower in patients with poor clinical outcome (N=75) as compared to patients with good clinical outcome (N=200) (840 μg/L versus 970 μg/L; p< 0.0001), suggesting that zinc supplementation could be useful for patients with severe COVID-19.

In the current situation of COVID-19 pandemic, drug repurposing may be the best option over 53 the development of novel drugs to fight this new acute infectious disease. Among existing 54 drugs that are currently under evaluation for treating 55 hydroxychloroquine (HCQ) in combination with azithromycin (AZ) has been shown to be 56 effective and synergistic both in vitro 1 and in vivo 2 . Using this combination, we have recently 57 treated 3,737 COVID-19 patients and observed a lower mortality and better outcome as 58 compared to other regimens in Marseille public hospitals 3 . In parallel with our studies, an 59 empiric regimen combining HCQ, AZ and zinc sulfate was recently proposed for treating 60 outpatients with a reduced hospitalization risk 4 . Zinc is an essential metal in human being and 61 is involved in a wide range of biological processes as a cofactor and signaling molecule 5 . In 62 vitro, zinc demonstrated its antiviral activity through inhibition of Severe Acute Respiratory 63 Syndrome 1 (SARS-CoV-1) RNA polymerase 6 . Moreover, zinc is well known as an essential 64 element for immune function and resistance to infections 5 . Zinc deficiency is very common, 65 even in developing countries and is associated to increased risk of infectious diseases 66 (pneumonia, diarrhea, malaria) 5 . Conversely, zinc supplementation is associated with a 67 significant decrease in mortality during severe pneumonia 7 . Finally, it has also been 68 demonstrated that chloroquine derivatives are ionophores for intracellular uptake of zinc into 69 the lysosomes 5 . Based on this knowledge and the fact that some of our patients from our The study 74 Patients were included as a part of a previous work 3 and biochemical analysis were performed 75 as standard care. Patients were included between 2020, March, 1st and 2020, April, 16 th , with positive for SARS-CoV-2 and a blood sample available for the measurement of zinc 78 concentration that was collected following the positive testing. Zinc administration before 79 during the admission was an exclusion criterion. Patients were previously categorized 80 according to their clinical outcome in two groups, as previously described 3 . Briefly, either 81 death or transfer to ICU or hospitalization for 10 days or more defined poor clinical outcome 82 (PClinO). Other patients were classified in the good clinical outcome (GO) group. The HCQ-retrospective study has recently shown that the addition of zinc to the chloroquine + azithromycin regimen is associated with a higher rate of patients discharged home and a lower 153 mortality in patients that did not require ICU when compared to chloroquine + azithromycin 

182 ( 

Zinc blood level Mean (SD)